| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 06/26/2013 | CN103179862A Chromobacterium bioactive compositions and metabolites |
| 06/26/2013 | CN103173216A Method for regulating in vivo/in vitro autophagy and toxicity of upconversion luminescent nano material |
| 06/26/2013 | CN103172707A Diagnosis marker Talin 1 segment for human immunodeficiency virus infection and application thereof |
| 06/26/2013 | CN103172706A Preparation method of chick-pea oligopeptide with antioxidation function |
| 06/26/2013 | CN103172705A Hepatitis C virus (HCV) B cell epitope peptide PUHI16 and application thereof |
| 06/26/2013 | CN103172704A Preparation method of antitumor small peptides FpAT |
| 06/26/2013 | CN103172703A Tuberculosis-resisting-drug-related efflux-protein-sourced tuberculosis resisting CTL (Cytotoxic T Lymphocyte) epitope peptide and application thereof |
| 06/26/2013 | CN103172702A Tuberculosis-resisting-drug-related efflux-protein-sourced tuberculosis resisting CTL (Cytotoxic T Lymphocyte) epitope peptide and application thereof |
| 06/26/2013 | CN103172701A Novel penetrating peptide and application thereof |
| 06/26/2013 | CN103172700A Pcr hot start by magnesium sequestration |
| 06/26/2013 | CN103172698A Antihypertensive polypeptides |
| 06/26/2013 | CN102336808B Oxidation cyclization method of Octreotide disulfide bond |
| 06/26/2013 | CN102229649B Preparation method of body protection polypeptide (BPC 157 peptide) |
| 06/26/2013 | CN102153630B Ring octapeptide and preparation method and application thereof in medicament making |
| 06/26/2013 | CN101918433B Peptides specific for hepatocellular carcinoma cells and applications thereof |
| 06/25/2013 | US8470971 Cell permeable p53 recombinant protein, polynucleotide encoding the same, and anti-cancer composition containing the same as active ingredient |
| 06/25/2013 | US8470783 For treating prostate cancer and malignant lymphoma; gene expression inhibition |
| 06/25/2013 | US8470782 Transglutaminase inhibitors and methods of use thereof |
| 06/25/2013 | US8470780 Methods and compositions related to targeting wounds, regenerating tissue, and tumors |
| 06/25/2013 | US8470778 VIP fragments and methods of use |
| 06/25/2013 | US8470768 Peptide epitopes of apolipoprotein B |
| 06/25/2013 | US8470765 Polypeptides and antibacterial or antiseptic use of same |
| 06/25/2013 | CA2513218C Peptides and uses thereof for preventing and treating alzheimer's disease(ad) |
| 06/25/2013 | CA2496422C Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor |
| 06/25/2013 | CA2480217C G-type peptides to ameliorate atherosclerosis |
| 06/20/2013 | WO2013089252A1 Modification of helper t cell-inducing polypeptide |
| 06/20/2013 | WO2013088395A1 Clicked somatostatin conjugated analogs for biological applications |
| 06/20/2013 | WO2013088194A1 Modified peptides and their use for treating autoimmune diseases |
| 06/20/2013 | WO2013088141A1 Polypeptide comprising the sequence egpwleeeeeayg linked to an immunogenic carrier |
| 06/20/2013 | WO2013087785A2 Bowman-birk protease inhibitor (bbi) binding peptides, and uses thereof in the separation, detection or purification of bbi |
| 06/20/2013 | WO2013073968A3 Agents for modulation of cell signalling |
| 06/20/2013 | US20130158234 Specific binding agents of human angiopoietin-2 |
| 06/20/2013 | US20130157961 Lytic-peptide-her2/neu (human epidermal growth factor receptor 2) ligand conjugates and methods of use |
| 06/20/2013 | US20130157960 Novel auristatin derivatives and use thereof |
| 06/20/2013 | US20130157949 Novel Peptides for Wound Healing |
| 06/20/2013 | US20130157946 Neurotrophic peptides |
| 06/20/2013 | US20130157943 Method and use of peptide antagonists of zonolin to prevent or delay the onset of diabetes |
| 06/20/2013 | US20130157928 Nociceptin mimetics |
| 06/20/2013 | US20130157338 Rhamm binding peptides |
| 06/20/2013 | US20130156819 Isolation of mesenchymal stem cells |
| 06/20/2013 | US20130156692 Vegf-specific capture agents, compositions, and methods of using and making |
| 06/19/2013 | EP2604624A1 Bowman-Birk protease Inhibitor (BBI) binding peptides, and uses thereof in the separation, detection or purification of BBI. |
| 06/19/2013 | EP2604281A1 Clicked somatostatin conjugated analogs for biological applications |
| 06/19/2013 | CN1668335B Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s) |
| 06/19/2013 | CN103163235A Deletion peptide and detection method for peptide phase 16 of solid-phase synthesis thymulin alpha1 |
| 06/19/2013 | CN103163234A Deletion peptide, non-peptide impurities and detection method for peptide phase 11 of solid-phase synthesis thymulin alpha1 |
| 06/19/2013 | CN103159835A Lys and oligopeptide-modified curcumin derivatives, and synthesis and medical application thereof |
| 06/19/2013 | CN103159834A Sendai virus antigen peptide and application thereof in detecting Sendai virus infection |
| 06/19/2013 | CN103159833A Sendai virus antigen peptide and application thereof in detecting Sendai virus infection |
| 06/19/2013 | CN103159832A Peptide with neuroprotective effect, preparation method thereof, pharmaceutical composition and purpose |
| 06/19/2013 | CN103159831A Pentapeptide, polypeptide, cyclopeptide derivative, compound and medicament and application of pentapeptide |
| 06/19/2013 | CN103159830A Lipopeptide compounds |
| 06/19/2013 | CN103159829A Extraction method for daptomycin |
| 06/19/2013 | CN102516365B Anti-HIV (human immunodeficiency virus) polypeptide of Tibetan dolphin scorpion |
| 06/19/2013 | CN102351948B Antithrombotic medicine RWR for specifically identifying platelet alpha<IIb>beta3 |
| 06/19/2013 | CN102351947B Ev71早期诊断方法及试剂盒 Ev71 early diagnostic methods and kits |
| 06/19/2013 | CN102304171B Three alpha-conus polypeptides and use thereof |
| 06/19/2013 | CN102286079B Alpha type conotoxin peptides and applications thereof |
| 06/19/2013 | CN102257138B Tumor antigen peptide and use thereof |
| 06/19/2013 | CN102023219B Composition for detecting rheumatoid arthritis immune antibody by colloidal gold lateral chromatography |
| 06/19/2013 | CN102012431B CCP (Cyclic Citrullinated Peptide) used for detecting the immune antibody of rheumatoid arthritis with dot immuno-gold filtration assay |
| 06/19/2013 | CN102004154B Composition for detecting immune antibodies of rheumatoid arthritis by dot immunogold filtration assay |
| 06/19/2013 | CN101970462B Cyclic compound and salt thereof |
| 06/19/2013 | CN101914134B Linear epitope minimum motif peptide of human papilloma virus type 58 E7 protein |
| 06/19/2013 | CN101906144B Conjugate formed by conjugating one Arg-Gly-Asp-Val chain and two fatty alcohol chains by Asp, synthesis thereof and medical application thereof |
| 06/19/2013 | CN101819201B Polypeptide composition for detecting immune antibody of rheumatoid arthritis in vitro |
| 06/19/2013 | CN101602793B Immunoregulatory polypeptide for preventing and/or treating rheumatoid arthritis and application thereof |
| 06/19/2013 | CN101580538B WT1-origin HLA-DR-binding antigen peptide |
| 06/18/2013 | US8466258 Polypeptides, cyclic polypeptides and pharmaceutical comprising thereof for non invasive specific imaging of fibrosis |
| 06/18/2013 | US8465747 Identification, optimization and use of cryptic HLA-B7 epitopes for immunotherapy |
| 06/18/2013 | US8465746 Compositions and methods for treatment, research and therapeutic applications for malaria |
| 06/18/2013 | CA2513701C Dimerized peptide |
| 06/18/2013 | CA2481512C Peptide inhibitors of protein kinase c.gamma. for pain management |
| 06/18/2013 | CA2471717C Process of purification of a nona-or deca peptide from residual organic solvent |
| 06/18/2013 | CA2438273C Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of angiogenesis |
| 06/13/2013 | WO2013086143A1 Modified mini-hepcidin peptides and methods of using thereof |
| 06/13/2013 | WO2013086003A1 Antimicrobial agent, bacterial strain, biosynthesis, and methods of use |
| 06/13/2013 | WO2013085017A1 Pyridone derivative and medicine containing same |
| 06/13/2013 | WO2013085016A1 Pyridone derivative and medicine containing same |
| 06/13/2013 | WO2013084526A1 Biotin compound, biotin labeling agent, and protein aggregate |
| 06/13/2013 | WO2013082708A1 Cyclic peptide production |
| 06/13/2013 | WO2013041969A3 Didemnin biosynthetic gene cluster in tistrella mobilis |
| 06/13/2013 | WO2013030569A3 Cell- penetrating peptides having a central hydrophobic domain |
| 06/13/2013 | WO2013015668A3 Use of the peptide gk-1 expressed in the filamentous phage m13 for preparing pharmaceutical products that increase the effectiveness of the immune response induced by vaccine antigens or pathogens |
| 06/13/2013 | US20130150301 Therapeutic agents for regulating serum phosphorus |
| 06/13/2013 | US20130150300 Specific binding sites in collagen for integrins and use thereof |
| 06/13/2013 | US20130150298 Parstatin peptides |
| 06/13/2013 | US20130150297 Therapeutic agents for reducing parathyroid hormone levels |
| 06/13/2013 | US20130150294 Na+/K+-ATPase-Specific Peptide Inhibitors/Activators of Src and Src Family Kinases |
| 06/13/2013 | US20130150288 Treatment of viral infections |
| 06/13/2013 | US20130149372 Polypeptides for the Treatment or Prevention of Cancer and uses Thereof |
| 06/13/2013 | US20130149248 AVß6 PEPTIDE LIGANDS AND THEIR USES |
| 06/13/2013 | US20130149241 Peptide radiotracer compositions |
| 06/13/2013 | CA2858599A1 Cyclic peptide production |
| 06/13/2013 | CA2858164A1 Pyridone derivative and medicine containing same |
| 06/13/2013 | CA2855122A1 Modified mini-hepcidin peptides and methods of using thereof |
| 06/12/2013 | CN103153329A Novel cyclosporin derivatives for the treatment and prevention of a viral infection |
| 06/12/2013 | CN103146707A Adrenoleukodystrophy related genetic mutant and its detection reagent |
| 06/12/2013 | CN103145811A Method for synthesizing Alisporivir |
| 06/12/2013 | CN103145810A Method for preparing micafungin |